Relative Strength Chart Genome & Company
Stocks
A314130
KR7314130006
Biotechnology & Medical Research
|
End-of-day quote
Korea S.E.
2026-11-13
|
5-day change | 1st Jan Change | ||
| 3,150.00 KRW | -3.82% |
|
+0.16% | -54.22% |
| 09-20 | Genome & Company(KOSDAQ:A314130) added to S&P Global BMI Index | CI |
| 08-14 | Genome & Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENOME & COMPANY | Other Biotechnology & Medical Research | -3.82% | +0.16% | -54.22% | +4.13% | -82.60% | 123M |
-
|
-
|
-
|
- Stock Market
- Stocks
- A314130 Stock
- Charts Genome & Company
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
















